Background/Aims: Obesity is a major contributor to the growing prevalence of metabolic and cardiovascular diseases. This study was designed to investigate the effect of folic acid (FA) on obese mice by detecting the genome-wide expression profile of lncRNAs and mRNAs in the heart. Methods: Heart samples were collected from mice fed with standard diet (SD), highfat diet (HFD) and high-fat diet with FA intake (HFDF). LncRNAs and mRNAs between HFD and HFDF group were analyzed by lncRNA microarray. Nine lncRNAs and mRNAs were validated using quantitative reverse transcription polymerase chain reaction (qRT-PCR). Bioinformatics prediction was used to investigate the potential function of these differentially expressed lncRNAs. Co-expresson analysis was used to determine the transcriptional regulatory relationship of differentially expressed lncRNAs and mRNAs between two groups. Results: The expression of 58,952 lncRNAs and 20,145 mRNAs in HFD and HFDF groups was profiled by using microarrays. Gene Ontology and pathway analyses indicated that the biological functions of differentially expressed mRNAs were related to inflammation, energy metabolism, and cell differentiation. Co-expression networks composed of lncRNAs and mRNAs were also constructed to investigate the potential regulatory roles of differentially expressed lncRNAs on mRNAs. LncRNAs, namely, NONMMUT033847, NONMMUT070811, and NONMMUT015327, were validated through qRT-PCR, and these lncRNAs may be important factors regulating inflammation, energy metabolism, and cell differentiation. The expression levels of Dnajb1, Egr2, Hba-a1, Il1β, Cxcl2, and Tnfsf9 were significantly different between HFD and HFDF. Conclusions: Results suggested that FA may improve the cardiovascular function of obesity and contribute to those lncRNAs associated with inflammation and cell differentiation. In a nutshell, the present study identified a panel of lncRNAs and mRNAs that may be potential biomarkers or drug targets relevant to the high-fat diet related obesity.
Introduction
Recent obesity epidemic is a major contributor to the increasing prevalence of metabolic and cardiovascular diseases [1] . In many chronic inflammatory diseases, genetic and environmental factors are essential for the development of obesity and its associated diseases [2, 3] . Folic acid (FA) supplement can effectively reduce the homocysteine levels and insulin resistance of obese children and consequently prevent obesity-related complications, including cardiovascular and metabolic disorders [4] . Food fortified with FA also helps decrease the birth prevalence of specific congenital heart defects (CHDs) [5] .
The overexpression of interferon beta, an immune-modulating cytokine, likely attenuates high-fat diet (HFD)-induced adipose inflammation and protect animals against obesity development [6] . Eicosapentaenoic acid (EPA), an omega-3 fatty acid, improves the regenerative capacity of mouse skeletal muscle cells exposed to saturated fat and inflammation [7] . Therefore, obesity is associated with chronic low-grade inflammation, and inflammatory responses can induce detrimental metabolic effects. In obesity, chronic low-grade inflammation occurs in many organs, including, but not limited to, white adipose tissue (WAT), brown adipose tissue, pancreas, liver, brain, muscle, and intestines [8] [9] .
Genome-wide transcriptional studies have indicated that approximately 1% of the human genome produces biologically significant RNA transcripts, whereas a much larger proportion of the genome is transcribed into non-coding RNAs (ncRNAs) [10,] [11] , which are non-protein-coding transcripts longer than 200 nucleotides [12] and are possibly involved in the regulation of various molecular and cellular functions. Long non-coding RNAs (lncRNAs) are widely distributed in the human genome. More than 90% of the human genome is composed of non-coding RNAs [13] . Changes in the amount of lncRNAs can induce aberrant gene expression that contributes to various disease states and biological functions [14] . Thus far, 5,446 lncRNA genes have been identified in the human genome. However, the functions of these genes remain unclear. Therefore, the co-expression of lncRNAs and mRNA should be analyzed to help predict their functional roles in disease development as a foundation for further functional and mechanistic studies. lncRNAs common to white and brown fat are essential for adipogenesis [15] . For instance, lnc-RAP1 (Firre) is exclusively nuclear and interactive with the nuclear matrix factor hnRNP U to mediate transchromosomal interactions between loci encoding adipogenic factors [16] . Differentially expressed circulating lncRNAs and mRNAs have been identified through microarray analysis between obese and non-obese human subjects [17] . Nevertheless, lncRNA biomarkers have yet to be identified in the heart of an obese individual.
In this study, the expression patterns of lncRNAs and mRNAs in the heart of mice fed with HFDF and HFD were demonstrated and validated through quantitative reverse transcriptionpolymerase chain reaction (qRT-PCR). Gene-lncRNA co-expression networks were further constructed to determine interaction patterns among genes with their related co-expressed lncRNAs. Our results suggested that FA might significantly affect the cardiovascular function of obesity.
Materials and Methods

Ethics Statement
Male wild-type (WT) mice in a C57BL/6 background were bred and maintained in the Laboratory of Animal Experiments at the Capital Institute of Pediatrics, Beijing China. The study was approved by the Ethical Committee for the Capital Institute of Pediatrics.
Animal Models C57BL/6 background mice were purchased from HFK Bioscience Company. All of the mice used in the experiment were within 3 weeks old, maintained under specific pathogen-free conditions, and handled according to the animal welfare regulations of the Capital Institute of Pediatrics. Experimental procedures Preparation of array hybridization SBC 4x180K mouse lncRNA microarrays were custom-designed by using Agilent eArray according to the manufacturer's recommenda tions (https://earray.chem.agilent.com/earray). The microarray contained 20,145 mRNA probes and 58,952 lncRNA probes. The lncRNA sequence was derived from four databases, namely GENCODE v21, Ensembl, Noncode v4, and UCSC. After the labeled cRNAs were purified, each slide was hybridized and washed according to the manufacturer's instructions (Agilent Technologies). Raw data were normalized with quantile algo rithm and limma packages in R. Differentially expressed lncRNAs and mRNAs were identified in terms of p-value and fold change. Experiments and analyses were performed by Shanghai Biotechnology Corporation.
Quantitative real-time PCR
Total RNA was extracted from mice hearts using TRIzol reagent (Invitrogen, USA) and then reversetranscribed with a high-capacity RNA-to-cDNA kit (Invitrogen, USA) according to the manufacturer's recommendations. The expression of significantly different lncRNAs and mRNAs in all of the subjects included in this study was determined through real-time PCR with SYBR Select Master Mix (Invitrogen, USA), and GAPDH was used as an internal control. For quantitative results, the expression of each lncRNA was represented as fold change by using 2-ΔΔCt methods. Differences in the lncRNA expression between HFDF and HFD were analyzed with Student's t-test. P < 0.05 was considered significant. The primers used in this study are listed in Table 1 .
Table 1. Verification of gene expression changes by qRT-PCR. Primers used in this paper
Functional group analysis Gene Ontology (GO) terms were searched from GO Database (http://www. geneontology. org/). P-values for differentially expressed genes in all of the GO categories were calculated, and the threshold of significance was defined as P < 0.05. Differentially expressed mRNAs were subjected to pathway analysis through KEGG (http://www.genome. jp/kegg/). Signaling pathways were analyzed on the basis of significance level with P < 0.05 as the threshold.
Co-expression network
Gene co-expression networks were constructed according to the normalized signal intensity of individual genes to identify interactions among genes and lncRNAs [29] . Data were preprocessed by considering the median gene expression value of all transcripts expressed from the same coding gene but without providing a special treatment of the lncRNA expression value. These data were then screened for differentially expressed lncRNAs and mRNAs and removed from the dataset. For each analyzed pair of
Results
Body weight, glucose tolerance and plasma adipokine levels of the three mouse groups
After 12 weeks of treatment, changes in body weight between the HFD and HFDF groups were closely similar. And the body weight of HFD group were significant increased than that of SD group since 3 weeks of treatment (P < 0.05, Fig. 1A ). However, glucose tolerance test were significant improved, indicative of improved glucose tolerance (P< 0.05, Fig. 1B ). Plasma leptin levels in the HFD group were remarkably higher than those in the HFDF group, and no significant differences in insulin, resistin, and PAI-1(P < 0.05, Fig. 1C ).
Differentially expressed lncRNAs
A genome-wide analysis of lncRNA and mRNA expression was performed to profile differentially expressed lncRNAs and mRNAs in FA intake and matching obesity. Hierarchical clustering was analyzed according to the lncRNAs and mRNAs expression values in the microarray (Fig. 2) . The microarray data revealed that 220 genes were differentially expressed between the two groups. Of these genes, 122 lncRNAs were up-regulated and 98 lncRNAs were down-regulated (fold change ≥ 1.5, P <0.05). Hierarchical clustering analysis was conducted to arrange specimens into groups according to their expression levels, and the top 20 differentially expressed lncRNAs are listed in Table 2 .
Differentially expressed mRNAs
A total of 101 mRNAs were differentially expressed between the two groups by using the same criteria of lncRNAs. Of these genes, 88 mRNAs were up-regulated and 13 mRNAs 
Function analysis of differentially expressed genes
Differentially expressed mRNAs were subjected to GO enrichment analysis to identify GOs with higher confidence. Enrichment indicates the significance of a specific function. As enrichment increases, the corresponding function is more specific and thus helps identify GOs with a more concrete functional description in experiments. These functional analyses were performed for all of the differentially expressed mRNAs. GOs associated with differentially expressed transcripts were "negative regulation of transcription from RNA polymerase II promoter," "multicellular organismal development," and "transport." Gene ontology analysis which primarily related to transport, cell development, metabolic process are shown in Fig.  3A . Pathway analysis indicated that 36 pathways were significantly enriched among the differentially expressed transcripts. Many of these pathways, such as "Cytokine-cytokine receptor interaction pathway," "Osteoclast differentiation pathway," "MAPK signaling pathway," "Metabolic pathways," and "Folate biosynthesis," were linked to inflammation, energy metabolism, and cell differentiation. The pathways which related to inflammation, metabolism and differentiation are shown in Fig. 3B .
Co-expression analysis between differentially expressed lncRNAs and coding genes in HFD and HFDF
Pearson correlation was calculated and general coding-noncoding gene co-expression networks were constructed in each of the HFD and HFDF groups with the differentially expressed lncRNAs and mRNAs from this study to determine the transcriptional regulatory relationship. A total of 432 co-expression edges connecting 136 nodes, with 91 coding changes in the degree within the network. The first 15 lncRNAs and mRNAs with the largest changes in the degree between HFD and HFDF are shown in Table 4 . These genes primarily participate in cytokine-cytokine receptor interaction, osteoclast differentiation, MAPK signaling pathway, Jak-STAT signaling pathway, neurotrophin signaling pathway, and folate biosynthesis. These results indicate that the lncRNAs in the network likely perform similar functions and thus might play a vital role in the molecular regulation of obesity.
QRT-PCR validation NONMMUT033847, NONMMUT070811, NONMMUT015327, Egr2, Dnajb1, and Hba-a1 were chosen to validate our microarray results (Fig. 5A) . The relative genes involved in the cytokine-cytokine receptor interaction pathway (Il1β, Cxcl2, and Tnfsf9) were also detected through qRT-PCR (Fig. 5B) . QRT-PCR results are consistent with microarray findings.
Discussion
In this study, the genome-wide expression profile of lncRNAs and mRNAs in the heart of mice fed with SD and HFD were investigated through microarray. A total of 220 lncRNAs, including 122 up-regulated and 98 down-regulated were identified to be differentially expressed between the two groups of mice. Simultaneously, 101 differentially expressed protein coding mRNAs from the same chip were also identified, including 88 up-regulated and 13 down-regulated mRNAs. The differences in the expression of lncRNAs and mRNAs detected through qRT-PCR were consistent with those observed through microarray.
Cardio-metabolic diseases are characterized as a combination of multiple risk factors of cardiovascular diseases (CVD) and metabolic diseases, including diabetes mellitus, dyslipidemia, hypertension, and abdominal obesity [19] . Childhood obesity is a chronic and complex metabolic disorder, which is associated with a high risk of various medical and psychosocial consequences [20] . CVD and type 2 diabetes mellitus are the most common preventable complications of childhood obesity. The presence of biochemical indicators, such as insulin resistance, hyperinsulinemia, and hyperhomocysteinemia, are associated with the early phase of these conditions, and proper interventions can prevent the development of complications [21, 22] .
The role of FA in metabolic health has been reported. Silva et al. revealed that FA deficiencies are found more frequently among individuals subjected to gastric bypass than gastric banding of bariatric techniques [23] . In an urban low-income prospective birth cohort, maternal plasma folate concentrations exhibit an L-shaped association with child overweight or obesity sufficient folate concentrations provide beneficial effects on individuals, especially obese mothers [24] . Dehkordi demonstrated that FA in two examined doses can be a safe and effective supplement for obese children to reduce homocysteine levels and insulin resistance; consequently, FA can prevent obesity-related complications, including cardiovascular and metabolic disorders [4] . The homocysteine-reducing effects of FA supplementation are observed in obese children [25] . Inflammation is increased in rats fed with high-fat-adequate FA (HF-AFA), and this increase is associated with impaired glucose tolerance compared with HF-EFA-fed rats. FA induces the PPARγ expression and triglyceride accumulation in 3T3-L1 cells [26] . FA may influence the pathogenesis of CHDs through other more complex pathways, including epigenetic mechanisms responsible for transgenerational effects [27] . Epigenetic mechanisms are possibly implicated in this process because the beneficial effects of FA fortification in reducing the prevalence of CHDs at birth may require more than one generation to become fully apparent [27] . In a Hungarian randomized trial, the birth prevalence of congenital cardiovascular anomalies is lower among women prescribed with periconceptional multivitamins, including FA, and trace element supplementation than among women given with supplemental trace elements only [28] . Our results demonstrated that NONMMUT033847, NONMMUT070811, and NONMMUT015327 were down-regulated in the HFDF group. QRT-PCR results validated our microarray data, which indicated that identified lncRNAs might play an important role in improving the cardiovascular functions during obesity.
Considering the importance of the cytokine-cytokine receptor interaction pathway, we focused on Csf2rb, Cxcl2, Eda2r, Il10rα, Il1β, Lif, Tnfrsf10b, and Tnfsf9. These genes are involved in the regulation of cell development, activation, growth, and motility. Nehete et al. observed the plasma-circulating levels of pro-inflammatory Th-1 cytokines, interferon gamma, interleukin-6, interleukin-12p40, tumor necrosis factor, soluble CD40 ligand, and interleukin-1β, and those of anti-inflammatory Th-2 cytokines, interleukin-4, interleukin-RA, interleukin-10, and interleukin-13 increase in overweight and obese chimpanzees [29] . In cytokines and chemokines in WBCs, TNF-SF5, 7, and 9 and CCL 8 and 10 are significantly higher in children with type 1 diabetes than in healthy children [30] . Chemokine ligand-2 (CXCL2), a WAT, produces up-regulated chemokines in obesity. Activated neutrophils in obesity may influence the functions of visceral WAT endothelial cells and contribute to WAT inflammation [31] . Our PCR results indicated that Il1β, CXCL2, and Tnfsf9 are significantly higher in the HFDF group than in the HFD group. Hba-a1 was down-regulated and Dnajb1 and Egr2 were up-regulated in the HFDF group. QRT-PCR results validated our microarray data.
This study was limited by the following. (i) GO and pathway analyses are required to further investigate the relationships among noncoding RNAs, coding RNAs, and proteins. (ii) LncRNAs and mRNAs validated by qPCR should be further tested on cell level.
In summary, this study identified the expression patterns of lncRNAs and mRNAs in the heart of mice fed with HFD and HFDF. LncRNAs were detected as a potential regulatory factor of obesity most likely through inflammation, energy metabolism, and cell differentiation. Further work should be performed to understand the biological functions and molecular mechanisms of specific lncRNAs implicated in obesity.
